The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells (Q38920728)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

neuroendocrine tumor

1 reference

based on heuristic

inferred from title

prostate adenocarcinoma

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

10

object named as

Naoya Masumori

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Taiji Tsukamoto

9

object named as

Taiji Tsukamoto

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Toshiaki Tanaka

3

object named as

Toshiaki Tanaka

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Kohei Hashimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yuki Kyoda

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Toshihiro Maeda

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ko Kobayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Kohsuke Uchida

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hiroshi Kitamura

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Koichi Hirata

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

12 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

283-295

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Bloodborne biomolecular markers in prostate cancer development and progression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Small cell carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Molecular characterization of prostatic small-cell neuroendocrine carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Understanding the lethal variant of prostate cancer: power of examining extremes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

The gelsolin family of actin regulatory proteins: modular structures, versatile functions.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Loss of Gelsolin expression in human ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Rho GTPases: signaling, migration, and invasion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Wnt/beta-catenin signaling: components, mechanisms, and diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

The many faces of neuroendocrine differentiation in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

A role for neurotensin in bicalutamide resistant prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Induction of human fibroblast proliferation by epidermal growth factor (EGF): enhancement by an EGF-binding arginine esterase and by ascorbate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Molecular cloning of a levocabastine-sensitive neurotensin binding site

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.165

21 January 2018

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelsolin: a candidate for suppressor of human bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in prostatic carcinoma: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25581609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LABINVEST.2014.165

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38920728&oldid=2202295151"